POZEN Challenges 52-Week Highs (POZN)

Posted in pre-market 
May 3rd, 2010

POZEN, Inc. (NASDAQ: POZN) is trading higher after Friday’s news after the closing bell that the FDA approved the its arthritis treatment Vimovo.  Shares closed down 10% on Friday at $10.85, but the shares went higher in after hours trading by 21% at $13.15 on over 5.9 million shares combined in regular and after-hours trading.

This morning we have shares are up 17.5% at $12.75 on 700,000 shares as of 8:24 AM EST.

The prior 52-week range is $5.16 to $12.68, so we’d watch to see if that prior 52-week will hold here in regular trading hours.


Comments are closed